Trends in Hospitalization and Mortality for Influenza and Other Respiratory Viruses During the COVID-19 Pandemic in the United States

Overview

Journal Vaccines (Basel)

Date 2023 Feb 28

PMID 36851289

Authors

Adeel Nasrullah

Karthik Gangu

Ishan Garg

Anam Javed

Hina Shuja

Prabal Chourasia

Rahul Shekhar

Abu Baker Sheikh

Affiliations

Soon will be listed here.

Abstract

Seasonal epidemics of respiratory viruses, respiratory syncytial virus (RSV), influenza viruses, parainfluenza viruses (PIVs), and human metapneumovirus (MPV) are associated with a significant healthcare burden secondary to hundreds of thousands of hospitalizations every year in the United States (US) alone. Preventive measures implemented to reduce the spread of SARS-CoV-2 (COVID-19 infection), including facemasks, hand hygiene, stay-at-home orders, and closure of schools and local/national borders may have impacted the transmission of these respiratory viruses. In this study, we looked at the hospitalization and mortality trends for various respiratory viral infections from January 2017 to December 2020. We found a strong reduction in all viral respiratory infections, with the lowest admission rates and mortality in the last season (2020) compared to the corresponding months from the past three years (2017-2019). This study highlights the importance of public health interventions implemented during the COVID-19 pandemic, which had far-reaching public health benefits. Appropriate and timely use of these measures may help to reduce the severity of future seasonal respiratory viral outbreaks as well as their burden on already strained healthcare systems.

Citing Articles

Integrating transcriptomics, eQTL, and Mendelian randomization to dissect monocyte roles in severe COVID-19 and gout flare.

Li J, Yang G, Liu J, Li G, Zhou H, He Y Front Genet. 2024; 15:1385316.

PMID: 39385934 PMC: 11461236. DOI: 10.3389/fgene.2024.1385316.

Respiratory Viral Testing Rate Patterns in Young Children Attending Tertiary Care Across Western Australia: A Population-Based Birth Cohort Study.

Taye B, Sarna M, Le H, Levy A, Minney-Smith C, Richmond P Influenza Other Respir Viruses. 2024; 18(9):e70005.

PMID: 39225070 PMC: 11369639. DOI: 10.1111/irv.70005.

Outcomes of COVID-19 and Influenza in Cerebral Palsy Patients Hospitalized in the United States: Comparative Study of a Nationwide Database.

Quazi M, Shakir M, Faiz Z, Quraishi I, Nasrullah A, Ikram H Viruses. 2024; 16(8).

PMID: 39205258 PMC: 11359358. DOI: 10.3390/v16081284.

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza-A Territory-Wide Study.

Kwok W, Lung D, Tam T, Yap D, Ma T, Tsui C Vaccines (Basel). 2024; 12(7).

PMID: 39066342 PMC: 11281690. DOI: 10.3390/vaccines12070704.

Preventing respiratory syncytial virus in older adults.

Perry D, Allan G Can Fam Physician. 2024; 70(4):258.

PMID: 38627002 PMC: 11280667. DOI: 10.46747/cfp.7004258.

References

Piroth L, Cottenet J, Mariet A, Bonniaud P, Blot M, Tubert-Bitter P . Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2020; 9(3):251-259. PMC: 7832247. DOI: 10.1016/S2213-2600(20)30527-0. View

Tempia S, Walaza S, Bhiman J, McMorrow M, Moyes J, Mkhencele T . Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021; 26(29). PMC: 8299743. DOI: 10.2807/1560-7917.ES.2021.26.29.2001600. View

Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N . Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan. Emerg Infect Dis. 2021; 27(11):2969-2970. PMC: 8544984. DOI: 10.3201/eid2711.211565. View

Tang M, Li Y, Chen X, Lin H, Jiang Z, Gu D . Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China. Med Sci Monit. 2021; 27:e929783. PMC: 7789049. DOI: 10.12659/MSM.929783. View

Groves H, Papenburg J, Mehta K, Bettinger J, Sadarangani M, Halperin S . The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based study. Lancet Reg Health Am. 2022; 7:100132. PMC: 8913102. DOI: 10.1016/j.lana.2021.100132. View

Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M . Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020. Lancet Reg Health Eur. 2021; 6:100103. PMC: 8454829. DOI: 10.1016/j.lanepe.2021.100103. View

Garg I, Shekhar R, Sheikh A, Pal S . Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections. Infect Dis Rep. 2022; 14(4):558-568. PMC: 9394296. DOI: 10.3390/idr14040059. View

Suntronwong N, Thongpan I, Chuchaona W, Lestari F, Vichaiwattana P, Yorsaeng R . Impact of COVID-19 public health interventions on influenza incidence in Thailand. Pathog Glob Health. 2020; 114(5):225-227. PMC: 7480427. DOI: 10.1080/20477724.2020.1777803. View

Solomon D, Sherman A, Kanjilal S . Influenza in the COVID-19 Era. JAMA. 2020; 324(13):1342-1343. DOI: 10.1001/jama.2020.14661. View

10.

Agha R, Avner J . Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. 2021; 148(3). DOI: 10.1542/peds.2021-052089. View

11.

McGovern I, Bogdanov A, Cappell K, Whipple S, Haag M . Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic. Vaccines (Basel). 2022; 10(10). PMC: 9612058. DOI: 10.3390/vaccines10101610. View

12.

Friedrich F, Ongaratto R, Scotta M, Veras T, Stein R, Lumertz M . Early Impact of Social Distancing in Response to Coronavirus Disease 2019 on Hospitalizations for Acute Bronchiolitis in Infants in Brazil. Clin Infect Dis. 2020; 72(12):2071-2075. PMC: 7543304. DOI: 10.1093/cid/ciaa1458. View

13.

Garg I, Hanif H, Javed N, Abbas R, Mirza S, Javaid M . COVID-19 Vaccine Hesitancy in the LGBTQ+ Population: A Systematic Review. Infect Dis Rep. 2021; 13(4):872-887. PMC: 8544378. DOI: 10.3390/idr13040079. View

14.

Chow E, Uyeki T, Chu H . The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2022; 21(3):195-210. PMC: 9574826. DOI: 10.1038/s41579-022-00807-9. View

15.

Sullivan S, Carlson S, Cheng A, Chilver M, Dwyer D, Irwin M . Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020; 25(47). PMC: 7693168. DOI: 10.2807/1560-7917.ES.2020.25.47.2001847. View

16.

Chiappelli F, Fotovat L . Virus interference in CoViD-19. Bioinformation. 2023; 18(9):768-773. PMC: 10326336. DOI: 10.6026/97320630018768. View

17.

Berencsi G, Kapusinszky B, Rigo Z, Szomor K . Interference among viruses circulating and administered in Hungary from 1931 to 2008. Acta Microbiol Immunol Hung. 2010; 57(2):73-86. DOI: 10.1556/AMicr.57.2010.2.1. View

18.

Olsen S, Winn A, Budd A, Prill M, Steel J, Midgley C . Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021; 70(29):1013-1019. PMC: 8297694. DOI: 10.15585/mmwr.mm7029a1. View

19.

Holshue M, DeBolt C, Lindquist S, Lofy K, Wiesman J, Bruce H . First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10):929-936. PMC: 7092802. DOI: 10.1056/NEJMoa2001191. View

20.

Kim T, Kim J, Shim H, Yun S, Jang J, Huh H . Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus. J Virol Methods. 2021; 298:114304. PMC: 8482523. DOI: 10.1016/j.jviromet.2021.114304. View